Market Insights Health Pharmacies OTC Products

Digestive & Intestinal Remedies (Pharmacies) - Sudan

Sudan

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$14.68m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.20%, resulting in a market volume of US$17.18m by 2029.
In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
In relation to total population figures, per person revenues of US$0.30 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

Market

Region

Region comparison

Currency

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Sudan is experiencing steady growth and development. Customer preferences in the Digestive & Intestinal Remedies market in Sudan are driven by the increasing awareness of digestive health and the growing number of gastrointestinal disorders in the country. Consumers are seeking effective remedies to alleviate symptoms such as indigestion, bloating, and constipation. They are also looking for products that are safe, affordable, and easily accessible through pharmacies. Trends in the market indicate a shift towards natural and herbal remedies. Consumers are becoming more conscious of the potential side effects of synthetic drugs and are turning to natural alternatives. This trend is in line with the global movement towards holistic health and wellness. As a result, there is a growing demand for herbal digestive remedies made from ingredients such as ginger, peppermint, and chamomile. Local special circumstances in Sudan contribute to the development of the Digestive & Intestinal Remedies market. The country has a high prevalence of gastrointestinal disorders due to factors such as poor sanitation, contaminated water sources, and limited access to healthcare facilities. As a result, there is a significant need for effective remedies to address these health issues. The local market is also influenced by cultural practices and traditional medicine, with many consumers relying on herbal remedies that have been passed down through generations. Underlying macroeconomic factors also play a role in the development of the market. Sudan has a growing middle class with increasing disposable income, which allows consumers to spend more on healthcare products. Additionally, the government's efforts to improve healthcare infrastructure and access to essential medicines have contributed to the growth of the pharmaceutical sector, including the Digestive & Intestinal Remedies market. In conclusion, the Digestive & Intestinal Remedies market in Sudan is developing due to customer preferences for safe and effective remedies, the trend towards natural and herbal products, local special circumstances such as high prevalence of gastrointestinal disorders, and underlying macroeconomic factors such as a growing middle class and government initiatives to improve healthcare infrastructure.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.